Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study.

[1]  T. Morgan,et al.  Alcohol and hepatocellular carcinoma. , 2004, Gastroenterology.

[2]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[3]  A. Mantovani,et al.  [Some facts on PCB pollution in Brescia, Northern Italy]. , 2003, Epidemiologia e prevenzione.

[4]  A. Tverdal,et al.  Coffee intake and mortality from liver cirrhosis. , 2003, Annals of epidemiology.

[5]  Chien-Jen Chen,et al.  Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. , 2003, American journal of epidemiology.

[6]  L. Covolo,et al.  Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. , 2003 .

[7]  C. la Vecchia,et al.  Does coffee protect against hepatocellular carcinoma? , 2002, British Journal of Cancer.

[8]  A. Constable,et al.  Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  W. London,et al.  Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  C. la Vecchia,et al.  Does coffee protect against liver cirrhosis? , 2002, Annals of epidemiology.

[11]  S. Porru,et al.  Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.

[12]  C. Tiribelli,et al.  The spectrum of liver disease in the general population: lesson from the Dionysos study. , 2001, Journal of hepatology.

[13]  G. Corrao,et al.  Coffee, caffeine, and the risk of liver cirrhosis. , 2001, Annals of epidemiology.

[14]  M. Coleman,et al.  Coffee consumption and serum aminotransferases in middle-aged Japanese men. , 2001, Journal of clinical epidemiology.

[15]  K. Suzuki,et al.  Lifestyle and serum gamma-glutamyltransferase: a study of middle-aged Japanese men. , 2000, Occupational medicine.

[16]  F. Callea,et al.  Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  M. Hara,et al.  Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. , 2000, American journal of epidemiology.

[18]  M. Coleman,et al.  Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan. , 1999, Annals of epidemiology.

[19]  Umberto Gelatti,et al.  Case‐control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol , 1999 .

[20]  F. Zerah,et al.  Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics , 1998, Biological Psychiatry.

[21]  K. Tanaka,et al.  Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. , 1998, International journal of epidemiology.

[22]  S. Porru,et al.  Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study , 1998, European Journal of Epidemiology.

[23]  E. Vartiainen,et al.  Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. , 1997, American journal of epidemiology.

[24]  F. Pintus,et al.  Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants , 1996, European Journal of Epidemiology.

[25]  D. Trichopoulos,et al.  A case‐control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma , 1995, International journal of cancer.

[26]  G. Friedman,et al.  Coffee, tea, and mortality. , 1993, Annals of epidemiology.

[27]  E. Casiglia,et al.  Unexpected effects of coffee consumption on liver enzymes , 1993, European Journal of Epidemiology.

[28]  A. Klatsky,et al.  Alcohol, Smoking, Cofee, and Cirrhosis , 1992 .

[29]  Keitaro Tanaka,et al.  Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case‐Control study in Fukuoka, Japan , 1992, International journal of cancer.

[30]  J K McLaughlin,et al.  Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.

[31]  J K McLaughlin,et al.  Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.

[32]  O H Førde,et al.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. , 1990, American journal of epidemiology.

[33]  L. Powell,et al.  Dose‐dependent pharmacokinetics of caffeine in humans: Relevance as a test of quantitative liver function , 1990, Clinical pharmacology and therapeutics.

[34]  Sadako Yamada,et al.  Fasting plasma caffeine level in cirrhotic patients: Relation to plasma levels of catecholamines and renin activity , 1989, Hepatology.

[35]  N. Benowitz,et al.  Coffee, alcohol, and the liver. , 1999, Annals of epidemiology.

[36]  G. E. Who,et al.  IARC monographs on the evaluation of carcinogenic risks to humans. v. 51: Coffee, tea, mate, methylxanthines and methylglyoxal , 1991 .

[37]  A. Nishikawa,et al.  Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. , 1990, Basic life sciences.